NDC product
CeraVe Developed with Dermatologists BHA Exfoliating Toner Acne Treatment
NDC 82046-291 · L'Oreal USA Products Inc
Key facts
| Product NDC | 82046-291 |
|---|---|
| Proprietary name | CeraVe Developed with Dermatologists BHA Exfoliating Toner Acne Treatment |
| Nonproprietary name | Salicylic acid |
| Substances | SALICYLIC ACID |
| Dosage form | LIQUID |
| Route | TOPICAL |
| Labeler | L'Oreal USA Products Inc |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M006 |
| Marketing start | May 19, 2026 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: